Double crosslinked chitosan and gelatin submicronic capsules entrapping aminoacid derivatives with potential antitumoral activity
Source abstract
Abstract
The aim of the article was the synthesis of novel l-phenylalanine derivatives with biological activity and their immobilization into polymeric particles. Thus, new formyl, acetyl and p-methoxy derivatives of l-phenylalanine with antitumor activity were synthesized by reaction with p-nitrobenzoyl chloride, followed by the reduction of nitro group and acylation of the new formed amino group. The chemical structures of the obtained aminoacid derivatives were determined by FT-IR, NMR, MS and elemental analyses. The compounds were encapsulated into chitosan- and gelatin-based submicronic capsules, prepared by double crosslinking (ionic and covalent) in a O/W/O double emulsion. The varying parameter polymer/ionic crosslinker molar ratio was seen to influence particle size, morphology, swelling degree, thermal properties, as well as their capacity to incorporate and release the new active principles. The in vivo acute toxicity and antitumoral effect of aminoacid derivatives in free form or encapsulated were evaluated on rats. Drug encapsulation into polymeric systems was proven to enhance antitumoral activity against implanted Guerin’s carcinoma.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Mora-Huertas CE, Fessi H, Elaissari A (2010) Int J Pharm 385:113–14210.1016/j.ijpharm.2009.10.018 ↗
2. Muzzarelli RAA (1997) Cell Mol Life Sci 53:131–14010.1007/PL00000584 ↗
3. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) J Control Release 100:5–2810.1016/j.jconrel.2004.08.010 ↗
4. Liu W, Chen G, He G, He Z, Qian Z (2011) J Mater Sci 46(20):6758–6757. doi: 10.1007/s10853-011-5632-310.1007/s10853-011-5632-3 ↗
5. Tabata Y, Ikada Y (1989) Pharm Res 6:422–42710.1023/A:1015991617704 ↗
6. Tabata Y, Ikada Y (1998) Adv Drug Deliv Rev 31:287–30110.1016/S0169-409X(97)00125-7 ↗
7. Kosmala JD, Henthorn DB, Peppas LB (2000) Biomaterials 21:2019–202310.1016/S0142-9612(00)00057-0 ↗
8. Rokhade AP, Agnihotri SA, Patil SA, Mallikarjuna NN, Kulkarni PV, Aminabhavi TM (2006) Carbohydr Polym 65(3):243–25210.1016/j.carbpol.2006.01.013 ↗
9. Bhagavan NV (2002) Protein and amino acid metabolism, medical biochemistry, 4th edn. Academic Press, San Diego
10. Nestor JJ (2007) In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, pp 573–60110.1016/B0-08-045044-X/00050-X ↗
11. Schermann JP (2008) Amino acids, peptides and proteins, spectroscopy and modeling of biomolecular building blocks. Elsevier, Amsterdam
12. Bruckner A, Garcia M, Marsh A, Gellman S, Diederichsen U (2003) Eur J Org Chem 10:3555–356110.1002/ejoc.200300269 ↗
13. Grebinişan D, Holban M, Şunel V, Popa M, Desbrieres J, Lionte C (2011) Cellul Chem Technol 45:571–577
14. Larionov LF (1961) Cancer Res 21:99–104
15. Lyttle MH, Satyam A, Hocker MD, Bauer KE, Caldwell CG, Hui HC, Morgan AS, Mergia A, Kauvar LM (1994) J Med Chem 37:1501–150710.1021/jm00036a016 ↗
16. Ware DC, Palmer BD, Wilson WR, Deny WA (1993) J Med Chem 36:1839–184610.1021/jm00065a006 ↗
17. Williams MG, Earhart RH, Bailey H, McGovern JP (1990) Cancer Res 50:5475–5480
18. Xiong J, Zhu HF, Zhao YJ, Lan YJ, Jiang JW, Yang JJ, Zhang SF (2009) Molecules 14:3142–315210.3390/molecules14093142 ↗
19. Zunino F, Savi G, Giuliani F, Gambetta R, Supino R, Tinelli S, Pezzoni G (1984) Eur J Cancer Clin Oncol 20(3):421–42510.1016/0277-5379(84)90091-9 ↗
20. Schwanstecher C, Meyer M, Schwanstecher M, Panten U (1998) Br J Pharmacol 123:1023–103010.1038/sj.bjp.0701686 ↗
21. Savile CK, Magloire VP, Kazlauskas RJ (2005) J Am Chem Soc 127:2104–211310.1021/ja045397b ↗
22. Walsh NE, Ramamurthy S, Schoenfeld L, Hoffman J (1986) Arch Phys Med Rehabil 67:436–439
23. Roiser JP, McLean A, Ogilvie AD, Blackwell AD, Bamber DJ, Goodyer I, Jones PB, Sahakian BJ (2005) Neuropsychopharmacology 30:775–78510.1038/sj.npp.1300659 ↗
24. Lauretani F, Maggio M, Nardelli A, Saccavini M, Ceda G (2008) J Am Geriatr Soc 56:1977–197810.1111/j.1532-5415.2008.01909.x ↗
25. Siddiqui AH, Stolk LM, Bhaggoe R, Hu R, Schutgens RB (1994) Dermatology 188(3):215–21810.1159/000247142 ↗
26. Anderer FA, Schlumberger HD, Frank H (1967) Structure 140(1):80–92
27. Basu C, Sunel V, Soldea C, Maftei-Sirbu D (1998) Al I Cuza Iasi Chim 6:51; Chem Abs (2000) 28758
28. Sunel V, Basu C, Soldea C, Maftei-Sirbu D (1998) Al I Cuza Iasi Chim 6:35; Chem Abs (2000) 28756
29. Barrett GC, Davies JC (2002) Amino acids, peptides and proteins. The Royal Society of Chemistry, Cambridge10.1039/9781847557438 ↗
30. Moise M, Şunel V, Profire L, Popa M, Desbrieres J, Peptu C (2009) Molecules 14:2621–263110.3390/molecules14072621 ↗
31. Şunel V, Dorohoi D, Moise M, Stroia L (2010) J Mol Liq 154:58–6010.1016/j.molliq.2010.04.001 ↗
32. Hamilton MA, Russo RC, Thurston RV (1978) Environ Sci Technol 12:41710.1021/es60140a017 ↗
33. Marchenko MM, Ketsa OV (2005) Ukr Biokhim Zh 77(2):141–146
34. Yurchenko OV, Todor IN, Tryndyak VP, Tregubova NA, Kovtonyuc OV, Solyanik GI, Kulik GI, Chekhun VF (2003) Exp Oncol 25:64–68
35. Yin Y, Li ZY, Sun Y, Yao K (2005) J Mater Sci 40(17):4649–4652. doi: 10.1007/s10853-005-3929-910.1007/s10853-005-3929-9 ↗
36. Basu SK, Kavitha K, Rupeshkumar M (2011) AAPS PharmSciTech 12(1):28–3410.1208/s12249-010-9537-2 ↗
37. Shu XZ, Zhu KJ (2001) J Microencapsul 18:237–24510.1080/02652040010000415 ↗
38. Jatariu (Cadinoiu) AN, Holban MN, Peptu CA, Sava A, Costuleanu M, Popa M (2012) Int J Pharm. http://dx.doi.org/10.1016/j.ijpharm.2012.06.02910.1016/j.ijpharm.2012.06.029 ↗
39. Peptu CA, Buhus G, Popa M, Perichaud A, Costin D (2010) J Bioact Compat Polym 25(1):98–11610.1177/0883911509350262 ↗
40. Hejazi R, Amiji M (2003) J Control Release 89:151–16510.1016/S0168-3659(03)00126-3 ↗
41. Shantha KL, Harding DRK (2002) Carbohydr Polym 48:247–25310.1016/S0144-8617(01)00244-2 ↗
42. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Hussain MD, Khan MA, Habib MY (2006) AAPS PharmSciTech 7(3):E38–E4610.1208/pt070361 ↗
43. Urrusuno RF, Calvo P, Lopez CR, Vila Jato JL, Alonso MJ (1999) Pharm Res 16:1576–158110.1023/A:1018908705446 ↗
44. Boonsongrit Y, Mueller BW, Mitrevej A (2008) Eur J Pharm Biopharm 69:388–39510.1016/j.ejpb.2007.11.008 ↗